The mild nonclassic form of steroid 21-hydroxylase deficiency is one of the most common autosomal recessive disorders in humans, occurring in almost 1% of Caucasians and about 3% of Ashkenazi Jews. Many patients with this disorder carry a Val-281-* Leu missense mutation in the CYP21 gene. This and most other mutations causing 21-hydroxyli? ;e deficiency are normally present in the CYP21P pseudogene and have presumably been transferred to CYP21 by gene conversion. To identify other potential nonclassic alleles, we used recombinant vaccinia virus to express two mutant enzymes carrying the mutations Pro-30-»Leu (normally present in CYP21P) and Ser-268->Thr (considered a normal polymorphism of CYP21). Whereas the activity of the protein carrying the Ser-»Thr mutation was indeed indistinguishable from the wild type, the enzyme with the Pro->Leu substitution had 60% of wild-type activity for 17-hydroxyprogesterone and about 30% of normal activity for progesterone when assayed in intact cells. When kinetic analysis of the latter mutant enzyme was performed in cellular lysates, the first order rate constants (maximum velocity/dissociation constant) for both substrates were reduced 10-to 20-fold compared with those for the wild-type enzyme. Pro-30 is conserved in many microsomal P450 enzymes and may be important for proper orientation of the enzyme with respect to the aminoterminal transmembrane segment. The Pro->Leu mutation was present in 5 of 18 patients with nonclassic 21-hydroxylase deficiency, suggesting that this mutation indeed acts as a nonclassic deficiency allele. (Molecular Endocrinology 5: 685-692, 1991)
INTRODUCTION
The nonclassic form of 21-hydroxylase deficiency is an attenuated or late-onset clinical variant of congenital 0888-8809/91 /0685-0692$03.00/0 Molecular Endocrinology Copyright © 1991 by The Endocrine Society adrenal hyperplasia. Although some patients with this disorder are asymptomatic, others display signs and symptoms of androgen excess. These may include premature pubarche, primary and secondary amenorrhea, hirsutism, acne, and infertility (1) . This disorder results from mutations in the CYP21 gene encoding the adrenal microsomal enzyme, P450c21 (P450XXI); this gene is located in the HLA major histocompatibility complex on chromosome 6p21.3 (2, 3) .
Nonclassic 21-hydroxylase deficiency is very common, occurring in about 1 % of the general Caucasian population and in about 3% of Ashkenazi (European origin) Jews (4, 5) . In the latter group of patients, the disease is associated with a characteristic HLA haplotype, B14;DR1. This haplotype is in genetic linkage disequilibrium with a mutation in CYP21, Val-281-»Leu (V281L) (6) . In vitro expression studies have shown that V281L adversely affects enzymatic activity (7) . The degree of enzymatic compromise is mild compared with the effects of other single amino acid substitutions present in patients with classic (more severe) 21-hydroxylase deficiency. In addition, the V281L mutant enzyme is strongly inhibited by physiological intraadrenal concentrations of progesterone, which may affect its behavior in vivo.
Other mutations causing nonclassic 21-hydroxylase deficiency have not as yet been identified. Because all 21-hydroxylase deficiency alleles characterized so far are the result of unequal crossing-over or gene conversion events between the functional CYP21 gene and the adjacent 98% homologous (8, 9) CYP21P pseudogene, we decided to examine a previously uncharacterized missense mutation present in the pseudogene that could account for other nonclassical alleles, Pro-30-» Leu (P30L). We also addressed the possibility that a single amino acid substitution considered to be a normal polymorphism, Ser-268-»Thr (S268T) (10, 11) , might, in fact, mildly compromise enzymatic function. We found that whereas S268T has no detectable effect on the enzyme, P30L is indeed a potential nonclassic 21-hydroxylase deficiency allele.
RESULTS

Analysis of Normal and Mutant Recombinant P450C21
Wild-type and mutant recombinant P450c21 were synthesized using recombinant vaccinia virus to infect COS-1 kidney epithelial cells. Densitometric analysis showed that 18 h postinfection the recombinant P450c21 represented about 1.2% of the total radiolabeled protein (Fig. 1) . The identity of the radiolabeled recombinant proteins was confirmed by immunoprecipitation ( Fig. 1) , using a rabbit polyclonal antibody against bovine P450c21. Similar amounts of recombinant proteins (measured as a percentage of the total incorporated radioactivity) were obtained from cells infected with the wild-type or mutant constructs, indicating that the mutations did not affect synthesis of the apoenzyme.
The activity of the recombinant wild-type, S268T, and P30L mutant enzymes was assayed in whole cells after a 30-min incubation with 17-hydroxyprogesterone or progesterone. P450c21-S268T had close to 100% of the wild-type activity for both substrates (80% con- ] methionine-cysteine were subjected to electrophoresis on 8.5% polyacrylamide gel, which was dried and autoradiographed. Mol wt markers are indicated. Lanes are: 1, cells infected only with the virus encoding T7 RNA polymerase (vTF7); 2-4, cells infected with vTF7 and vaccinia viruses encoding wild-type, S268T, and P30L P450c21, respectively. Percentages of total scanning densitometry measurements represented by P450c21 were 1.4% for wild-type, 1.0% for S268T, and 1.1% for P30L P450c21, respectively. Lanes 5-8, Immunoprecipitates of labeled cell lysates analyzed in parallel with the total cellular lysates. version of 17-hydroxyprogesterone to 11 -deoxycortisol and 60% conversion of progesterone to deoxycorticosterone). In contrast, P450c21-P30L had only 60% of the activity for 17-hydroxyprogesterone and about 25% of the activity for progesterone compared with the wildtype enzyme (Fig. 2) .
Apparent K m and maximum velocity (V max ) values for both 17-hydroxyprogesterone and progesterone were determined in nuclear free cellular lysates in the presence of 20% glycerol, a known stabilizing agent for P450c21 (12, 13) . There were marked differences in the apparent K m and V max between the wild-type and the mutant enzyme carrying the P30L substitution (Table 1). When activities are expressed as first order rate constants (V max /K m ), the P30L enzyme had a 12-fold decrease in the activity for 17-hydroxyprogesterone (10.6 vs. 0.85 /il/min-mg total protein). Both wild-type and P450c21-P30L metabolized progesterone more slowly than 17-hydroxyprogesterone, but the activity of the P30L enzyme was 21-fold lower than that of the wild-type enzyme for progesterone (V max /K m> 0.2 and 4.2 Atl/min-mg, respectively).
In the absence of glycerol, the activity of P450c21-S268T remained indistinguishable from that of the wildtype enzyme, whereas P450c21-P30L lost all activity after 15 min of incubation at 37 C (data not shown).
Subcellular location of the recombinant enzymes was determined by measuring enzymatic activity using 17-hydroxyprogesterone as the substrate in fractions from Percoll density gradients (Fig. 3 ). Microsomal and cytosolic fractions were identified by density (1.06-1.11 and 1.038-1.040 g/ml, respectively); in addition, cytosolic fractions were identified by lactate dehydrogenase activity, and microsomal fractions by the peak of NADPH-cytochrome P450c21 reductase immunoreactivity. Activity for all three recombinant P450c21 enzymes was found in the microsomal fractions along with immunoreactivity for NADPH-cytochrome reductase. A small proportion (5%) of the P450c21-P30L activity was also present in cytosolic fractions. Fraction tt
Fig. 3. Subcellular Fractionation of Wild-Type and Mutant Recombinant P450c21
Right panels, Fractions of Percoll density gradients were analyzed for density, activity of lactate dehydrogenase (LDH), and immunoreactivity of Western blot (quantitated by scanning densitometry) using rabbit antiserum against NADPH-cytochrome P450 reductase (NADPH-reductase). Determinations on one of three gradients are shown. Left panels, Fractions were assayed for 21-hydroxylase activity using 17-hydroxyprogesterone as a substrate. Activities in fractions are expressed as a percentage of the total activity obtained by integrating under each curve.
Hybridization Analysis of Patient Samples
The frequency of the P30L mutation was determined in 18 patients with nonclassic 21-hydroxylase deficiency who had at least one non-B14;DR1 haplotype and in 37 control subjects with no known endocrinological abnormality ( Table 2) . Exons 1-3 of CYP21 were amplified from DNA samples using the polymerase chain reaction (PCR), and the presence of P30L was assessed by hybridization of dot blots with allele-specific oligonucleotides.
Four of 18 patients were heterozygous and one was homozygous for P30L, while 2 of 37 control subjects carried this mutation. The difference in allele frequency between the patient and control groups was significant by Fisher's exact test (P < 0.01). In contrast to the genetic linkage disequilibrium between V281L and HLA-B14;DR1, there were no obvious associations between P30L and particular HLA antigens in the patient group.
Whereas many patients with nonclassic 21-hydroxylase deficiency are asymptomatic and are detected in 
family studies, all five patients carrying P30L were symptomatic. Only 9 of 13 nonclassic subjects who did not carry P30L were symptomatic. This difference was not statistically significant (P = 0.11) due to the small sample size. There was no significant difference in ACTH-stimulated 17-hydroxyprogesterone between the patients with and without the P30L mutation. Pedigree analysis was performed in one 21-hydroxylase deficiency family carrying P30L. Father and patient (patient 4 in Table 2 ) were heterozygous for the P30L mutation, whereas mother and patient were heterozygous for the I172N (14) mutation (Fig. 4) . Thus, the patient is a compound heterozygote, carrying a nonclassic mutation on the paternally transmitted chromosome and a classic mutation on the maternally trans- Table 3 . The father's DNA sample was not hybridized with the lle-172 probes. mitted chromosome. No other gene conversions were detected by serial dot blot hybridization. This family lacked the HLA-B14;DR1 haplotype found in genetic linkage disequilibrium with V281L. Hormonal studies were consistent with heterozygosity for 21 -hydroxylase deficiency in mother and father and with compound heterozygosity for a mild and severe CVP21 gene defect (15) in the proband, who was symptomatic with clitoromegaly, hirsutism, and delayed menarche.
DISCUSSION
Functional Effects of the P30L Mutation
All microsomal P450 enzymes have an amino-terminal tail that is rich in hydrophobic amino acid residues (16) . It has been demonstrated that this tail functions as a combined microsomal membrane insertion and stoptransfer signal (17, 18) , and that removal of the tail interferes with membrane association and enzymatic activity (19) . Following this tail, most microsomal P450s have a short segment that contains at least two proline residues, which are predicted to create a turn in the polypeptide chain that may serve to orient the enzyme properly with respect to the microsomal membrane. Therefore, we speculate that substitution of leucine for proline in the P30L mutation interferes with proper orientation of the enzyme. The lability of the enzyme upon cellular homogenization and the finding that some of the enzyme is associated with cytosolic fractions are both consistent with this idea. Many properties of the P30L enzyme are similar to those of the enzyme carrying V281L (7). These include relatively poor activity when progesterone is the substrate, recovery of a portion of the enzyme in cytosolic fractions of Percoll gradients, and lability of the activity upon disruption of the cells (although this is much more striking in the P30L enzyme). It is, thus, not surprising that P30L functions as a nonclassic 21-hydroxylase deficiency allele, as does V281L.
The P30L mutation has been identified in 5 of 18 of our patients with hormonal evidence of nonclassic 21-hydroxylase deficiency. Although there was no statistical difference (due to limited sample size) in the presence of clinical symptoms or in ACTH-stimulated 17-hydroxyprogesterone levels in patients with and without P30L, it is interesting to note that all four females presented with clitoromegaly. In the large experience of this clinical center, clitoromegaly has been detected in only about 7% of females with nonclassic 21-hydroxylase deficiency. Early pubarche, hirsutism, and oligomenorrhea are more common signs of virilization in this form of adrenal hyperplasia. Thus, although the P30L mutant enzyme expressed in vitro had physiological characteristics similar to those of the V281L enzyme, the clinical phenotype in these five patients is intermediate in severity between the classic and nonclassic phenotypes.
Frequency of the P30L Mutation
Screening studies in newborn populations (20) yield an estimate of a 2% carrier rate for all classic mutations, whereas population genetic studies predict a carrier rate as high as 16-33% for nonclassic alleles (4). The carrier rate of 5% for P30L in our small control sample is thus compatible with the notion that P30L accounts for about one third to one sixth of nonclassic alleles in the general population; indeed, P30L had an allele frequency of 17% in the nonclassic patients we examined. Approximately 36% of non-B14;DR1 nonclassic 21-hydroxylase deficiency haplotypes in a recent study (21) had no detectable mutations between the third and seventh exons by dot blot analysis; the P30L mutation, which was not tested for, might account for many of these uncharacterized alleles.
Mutations Causing 21-Hydroxylase Deficiency
Steroid 21-hydroxylase deficiency is unique among inherited diseases, in that all causative mutations described thus far apparently result from recombinations between the normally active gene and an adjacent pseudogene (21) (22) (23) . About 20-25% of these are deletions of CVP21 due to unequal crossing-over during meiosis, whereas the remainder are apparent gene conversions, i.e. transfers of deleterious mutations from the pseudogene to the active gene. The only reported mutation that is not a gene conversion, S268T, has, in fact, been found in normal individuals (10) , and studies reported here and elsewhere (24) demonstrate that this mutation has no apparent effect on enzymatic activity. It was found in a patient because it is often associated with a mutation in the second intron that causes CVP21 transcripts to be spliced aberrantly (11, 21, 25, 26) .
The extremely high incidence of gene conversions causing 21-hydroxylase deficiency alleles suggests that additional potential deficiency alleles might be demonstrated by prospectively examining other mutations present in the CVP21P pseudogene for functional effects, as was done in the present work for P30L. There is only one missense mutation causing an amino acid substitution that has not yet been found in patients with 21-hydroxylase deficiency: Asp-183^Glu (D183E). Additional mutations in the 5' flanking region or in introns should be examined for their effects on transcription and pre-mRNA processing, respectively.
MATERIALS AND METHODS
Site-Directed Mutagenesis
The vaccinia shuttle plasmid p21-T7-f1 contains a full-length human cDNA clone encoding P450c21. Single stranded copies of p21 -T7-f 1 were synthesized in £ coli CJ236 (dut-and ung-, obtained from Bio-Rad, Richmond, CA) in the presence of VSC-13 helper phage (27) . Complementary strands were synthesized in vitro using primers containing each desired mutation (CTGCACCTCCTGCCTCTTGCC for P30L and GCGCAGCCGACCATGGAAGAG for S268T) and modified T7 DNA polymerase (U.S. Biochemicals, Cleveland, OH). Double stranded DNA was ligated and transformed into E. coli strain MV1140. Plasmids containing each desired mutation were selected by colony hybridization, using each mutant oligonucleotide as a probe. The introduced mutations were verified by sequence analysis. The cDNA insert in p21-T7-f1 is in the middle of a copy of the vaccinia thymidine kinase gene; mutagenized p21-T7-f1 could thus be introduced into the vaccinia genome by homologous recombination (28) .
In Vitro Expression
COS-1 monkey kidney epithelial cells (American Type Culture Collection, Rockville, MD) were infected with vTF7 vaccinia virus encoding T7 RNA polymerase at a 500:1 multiplicity of infection (MOI) with or without parallel infection with virus containing wild-type or mutant P450c21 at 1:1 MOI. Cells were incubated for 18 h with Dulbecco's Modified Eagle's Medium (Gibco, Grand Island, NY) supplemented with 5% newborn calf serum, 10 jug/ml protoporphyrin-IX, and 18 /tg/ml human transferrin (Sigma, St. Louis, MO).
Assays of Enzymatic Activity
The radiochemical purity of each steroid precursor was confirmed by TLC. Enzymatic activity was assayed in whole cells or cell lysates 18 h postinfection, as previously described (7) . Assays in whole cells were performed in 35-mm wells using 1 ml medium containing 0.5 ^Ci [ 3 H]17-hydroxyprogesterone or progesterone (DuPont-New England Nuclear, Boston, MA) and 2 HM unlabeled substrate. To assay activity in cell lysates, the cells were washed twice with PBS (Gibco) and homogenized in hypotonic buffer [10 ITIM HEPES (pH 6.2), 10 mM NaCI, and 1.5 mM MgCI 2 ], using a Dounce homogenizer (Kontes Co., Vineland, NJ). Nuclei were removed by centrifugation at 800 x g for 10 min. Assays were carried out using 250 ^9 protein in 0.5 ml 100 mM KPO 4 buffer, pH 7.2, with the same amounts of labeled and unlabeled substrate as those used in whole cell assays (2 mM NADPH and 20% glycerol).
Reactions were extracted with methylene chloride, and products and reactants were resolved by TLC in chloroformacetone (70:30) for 17-hydroxyprogesterone or chloroformethyl acetate (80:20) for progesterone. Radioactivity was measured using a TLC analyzer or by liquid scintillation spectrophotometry.
Radiolabeling and Immunoprecipitation
Rabbit antibovine P450c21 serum was produced as previously described (7, 29) ; however, this serum is from a different rabbit than that used in previous studies.
Eighteen hours postinfection cells were incubated for 1 h in medium containing 0.25 mCi 35 S-labeled methionine-cysteine (ICN, Irvine, CA) without additional unlabeled methionine and cysteine. Cells were washed twice in PBS and lysed in buffer containing 0.05 M Tris-HCI (pH 7.5), 0.15 M NaCI, 1 % Nonidet P-40, 5 IDM EDTA, 0.25% sodium deoxycholate, 1 ITIM phenylmethylsulfonylfluoride, and 100 U/ml aprotinin for 30 min at 4 C. Cell lysates were precleared by three successive incubation with preimmune serum and 0.1 vol protein-A-Sepharose (Pharmacia LKB Biotechnology, Inc., Piscataway, NJ). Precleared supernatants were incubated for 2 h at 4 C with a 1:100 dilution of rabbit antibovine P450c21 serum, and antigen-antibody complexes were absorbed to protein-A-Sepharose. Pellets were washed three times in RIPA buffer [50 mM Tris-HCI (pH 7.5), 150 mM NaCI, 1 % Nonidet P-40, 0.1% sodium dodecyl sulfate (SDS), and 1 % sodium deoxycholate] (30), boiled in Laemmli sample buffer (31) , and subjected to electrophoresis in an 8.5% SDS-acrylamide gel along with an aliquot of the unprecipitated lysates.
Subcellular Fractionation
Microsomal fractions were collected using self-forming Percoll density gradients (32) . Infected cells were washed twice in cold PBS and harvested in 5 vol cold homogenization buffer (0.25 M sucrose and 1 mM EDTA, pH 6.8) in a Dounce homogenizer and centrifuged at 800 x g for 10 min. Nuclear free supernatants were layered on a cushion of 1 ml 60% sucrose and 4.4 ml Percoll suspension (density, 1.070 g/liter). Gradients were formed by centrifugation at 20,000 x g for 2 h at 4 C in a Beckman Ti80 rotor (Palo Alto, CA). Fractions of 0.25 ml were collected. Protein content and density were measured in each fraction. Fifty-microliter aliquots of each fraction were assayed for lactate dehydrogenase activity (33) and 21 -hydroxylase activity using 17-hydroxyprogesterone as a substrate. Immunoblot analysis was performed in all fractions using antisera to bovine NADPH-cytochrome P450 reductase (a gift from K. C. Cheng) and [ 125 l]protein-A (34).
PCR and Hybridization Analysis
Genomic DNA (0.5-1 ng) was amplified in two segments by the PCR, employing 21-mer primers that selectively amplified CyP21 and not the highly homologous CVP21P gene (26) . Fragment 1 represented a 677-basepair (bp) segment extend ing from exon 1 (primer sequence, 5'-TGGA-ACTGGTGGAAGCTCCGG-3') through the 8-bp deletion in exon 3 [primer sequence, 5'-AGCAGGGAGT/*GTCTCCCAAG-3' (italicized nucleotides represent the 8-bp deletion typically found in C/P21P)]. Fragment 2 was an approximately 1.5-kilobase fragment extending from the 8-bp deletion in exon 3 (primer sequence, 5'-TTGTCCTTGGG/*G>4CL4CTCC-3') through the eighth intron (primer sequence , 5'-GCTCGGGCTTTCCTCACTCAT-3'). Reactions were carried out in a 0.05-ml volume containing 50 mM KCI, 10 mM Tris-CI (pH 8.3), 1.5 mM MgCI 2 , 0.01% gelatin, 1 U Taq polymerase, 200 fiM dNTP, and 0.3 fiM of the respective primers. The reaction mix was covered with mineral oil, and DNA templates were subjected to denaturation at 94 C for 2 min, followed by 30 cycles consisting of 94 C for 1 min, 60 C for 1.5 min, and 72 C for 4 min. The final five cycles consisted of 94 C for 1 min, 60 C for 1.5 min, and 72 C for 10 min. Ten to 20 percent of the total reaction volume was dotted on nylon membranes after checking an aliquot of the PCR product for size and concentration on a 1 % agarose gel.
Serial hybridizations were performed with nine sets of endlabeled normal and mutant oligonucleotide probes representing point mutations that may be introduced into CVP21 from CVP21P by gene conversion ( Table 3 ). The presumption was made that DNA samples that were amplified with both sets of PCR primers did not have a gene conversion involving the 8-bp deletion in the third exon. Control samples on each blot consisted of the PCR-amplified cloned normal genomic CVP21 and CVP21P genes. Hybridization was performed overnight at 37 C in 6 x TEN [60 mM Tris (pH 8), 6 mM EDTA, and 600 mM NaCI], 0.5% SDS, and 5 x Denhardt's solution. Membranes were then washed twice for 10 min each at 45 and 55 C in 6 x TEN with 0.5% SDS, and finally at 60-64 C in 3 M tetramethylammonium chloride with 50 mM Tris (pH 8), 2 mM (35) . Autoradiography was performed using Kodak XAR film (Eastman Kodak, Rochester, NY) at -7 0 C for 4-24 h.
